B I09

Modify Date: 2024-04-05 10:45:18

B I09 structure	Common Name	B I09
	CAS Number	1607803-67-7	Molecular Weight	303.31
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₆H₁₇NO₅	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of B I09

B I09 is an IRE-1 RNase inhibitor, with an IC50 of 1230 nM.

Name	B I09

Description	B I09 is an IRE-1 RNase inhibitor, with an IC50 of 1230 nM.
Related Catalog	Signaling Pathways >> Cell Cycle/DNA Damage >> IRE1 Research Areas >> Cancer
Target	IC50: 1230 nM (IRE-1 RNase)[1].
In Vitro	B I09 is an IRE-1 RNase inhibitor, with an IC50 of 1230 nM[1]. Treatment of CLL cells with this inhibitor (B I09) mimick XBP-1 deficiency, including upregulation of IRE-1 expression and compromised BCR signaling. B I09 is highly effective in inhibiting splicing of XBP1 mRNA in human WaC3 cells and the expression of XBP-1s in LPS stimulated B cells[2].
In Vivo	B I09 has a halflife of approximately 1.5 hours and reaches its peak concentration of approximately 39 μM in mouse plasma serum 15 minutes after administration. Administration of B I09 to CLL tumor-bearing mice suppress leukemic progression by inducing apoptosis and do not cause systemic toxicity[2].
Animal Admin	Mice[2] Mice are intraperitoneally injected with B I09 (50 mg/kg) on the first 5 days of each week for 3 weeks[2].
References	[1]. Ranatunga S, et al. Synthesis of novel tricyclic chromenone-based inhibitors of IRE-1 RNase activity. J Med Chem. 2014 May 22;57(10):4289-301. [2]. Tang CH, et al. Inhibition of ER stress-associated IRE-1/XBP-1 pathway reduces leukemic cell survival. J Clin Invest. 2014 Jun;124(6):2585-98.

Molecular Formula	C₁₆H₁₇NO₅
Molecular Weight	303.31

DC Chemicals Limited
China
Product Name: B I09
Price: $Inquiry/100mg $Inquiry/250mg $Inquiry/1g
Purity: 98.0%
Stocking Period: 3 Day
Contact: Tony Cao

Get all suppliers and price by the below link:

B I09 suppliers